Evidence map›Paper›PMID 35935872›Full record

ArticleFrontiers in pharmacology2022

Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system.

Eugene Jeong, Scott D Nelson, Yu Su, Bradley Malin, Lang Li, You Chen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Eugene JeongDepartment of Biomedical Informatics, School of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Scott D NelsonDepartment of Biomedical Informatics, School of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Yu SuDepartment of Computer Science and Engineering, College of Engineering, the Ohio State University, Columbus, OH, United States.
Bradley MalinDepartment of Biomedical Informatics, School of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Lang LiDepartment of Biomedical Informatics, College of Medicine, the Ohio State University, Columbus, OH, United States.
You ChenDepartment of Biomedical Informatics, School of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Vanderbilt University Medical Center · USThe Ohio State University · US

Funding

Vanderbilt Biomedical Informatics Training ProgramT15LM007450 · NLM · VANDERBILT UNIVERSITY · PI Jessica S. Ancker, Bradley A. Malin · 2002 to 2026
$19.7M
Machine learning drives translational research from drug interactions to pharmacogeneticsR01LM014199 · NLM · OHIO STATE UNIVERSITY · PI You Chen, Lang Li · 2023 to 2026
$2.5M
NLM NIH HHS R01 LM014199NLM NIH HHS T15 LM007450
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

additive interactionCOVID-19discovery-drivendrug-drug interactionsFAERShypothesis generationlogistic regresionmultiplicative interaction

Identifiers

PMID35935872
PMCPMC9353301
OpenAlexW4286698381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.